We are pleased to announce the offering by Affin Hwang IB of up to 100,000,000 non-collateralised European-style cash settled call warrants over ordinary shares of SUNMED by way of market making.

SUNMED-CF is to be listed on the Structured Warrants Board of Bursa Malaysia Securities Berhad.

SUNMED-CF is constituted by the Deed Poll dated 22 October 2025. SUNMED-CF is subject to the terms and conditions of the Base Prospectus dated 7 November 2025, the First Supplementary Base Prospectus dated 1 December 2025, the Second Supplementary Base Prospectus dated 27 February 2026 and the Term Sheet for SUNMED-CF dated 26 March 2026.

A summary of the principal terms of the SUNMED-CF is set out in the attachment.